Literature DB >> 32531261

TDP-1/TDP-43 potentiates human α-Synuclein (HASN) neurodegeneration in Caenorhabditis elegans.

Linjing Shen1, Changliang Wang1, Liang Chen2, Ka Lai Leung1, Esther Lo1, Merja Lakso1, Garry Wong3.   

Abstract

TAR DNA binding protein (TDP-43) is a DNA/RNA binding protein whose pathological role in amyotrophic lateral sclerosis (ALS) and frontal temporal lobe dementia (FTLD) via formation of protein aggregates is well established. In contrast, knowledge concerning its interactions with other neuropathological aggregating proteins is poorly understood. Human α-synuclein (HASN) elicits dopaminergic neuron degeneration via protein aggregation in Parkinson's disease. HASN protein aggregates are also found in TDP-43 lesions and colocalize in Lewy Body Dementia (LBD). To better understand the interactions of TDP-43 and HASN, we investigated the effects of genetic deletion of tdp-1, the Caenorhabditis elegans ortholog of human TDP-43, as well as overexpression of TDP-43, in transgenic models overexpressing HASNWT and HASNA53T. Tdp-1 deletion improved the posture, movement, and developmental delay observed in transgenic animals pan-neuronally overexpressing HASNA53T, and attenuated the loss and impairment of dopaminergic neurons caused by HASNA53T or HASNWT overexpression. Tdp-1 deletion also led to a decrease in protein level, mRNA level and aggregate formation of HASN in living animals. RNA-seq studies suggested that tdp-1 supports expression of lysosomal genes and decreases expression of genes involved in heat shock. RNAi demonstrated that heat shock proteins can mediate HASN neuropathology. Co-overexpression of both human TDP-43 and HASNWT resulted in locomotion deficits, shorter lifespan, and more severe dopaminergic neuron impairments compared to single transgenes. Our results suggest TDP-1/TDP-43 potentiates HASN mediated neurodegeneration in C. elegans. This study indicates a multifunctional role for TDP-1/TDP-43 in neurodegeneration involving HASN.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  C. elegans; Lewy body dementia; Neurodegeneration; Parkinson's disease; TDP-1/TDP-43; tdp-43; α-Synuclein

Year:  2020        PMID: 32531261     DOI: 10.1016/j.bbadis.2020.165876

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  3 in total

1.  Prion-like C-Terminal Domain of TDP-43 and α-Synuclein Interact Synergistically to Generate Neurotoxic Hybrid Fibrils.

Authors:  Shailendra Dhakal; Courtney E Wyant; Hannah E George; Sarah E Morgan; Vijayaraghavan Rangachari
Journal:  J Mol Biol       Date:  2021-03-24       Impact factor: 5.469

Review 2.  Linking Parkinson's Disease and Melanoma: Interplay Between α-Synuclein and Pmel17 Amyloid Formation.

Authors:  Dexter N Dean; Jennifer C Lee
Journal:  Mov Disord       Date:  2021-05-22       Impact factor: 9.698

3.  Heparan sulfate proteoglycans mediate prion-like α-synuclein toxicity in Parkinson's in vivo models.

Authors:  Merry Chen; Julie Vincent; Alexis Ezeanii; Saurabh Wakade; Shobha Yerigenahally; Danielle E Mor
Journal:  Life Sci Alliance       Date:  2022-07-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.